DMMA-modified nanogel |
Acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and Dox delivery |
Dox |
Chemotherapy |
In vitro cell viability of MDA-MB-435s cells |
[75] |
polysaccharide-based nanogel |
Hyaluronic-Acid-Based pH-Sensitive Nanogels |
Dox |
Chemotherapy |
In vitro cell viability and In vivo mice model tumor volume evaluation |
[146] |
PEGylated PMAA-based nanogel |
Glutathione-sensitive nanogel |
Dox |
Chemotherapy |
In vitro cell viability of HepG2 cells |
[147] |
HA-based nanogel |
Self-targeting hyaluronate (HA) nanogels (CDDPHANG/Dox) |
Dox and Cisplatin |
Chemotherapy |
In vitro cell viability of MCF-7/ADR breast cancer cells |
[113,148] |
pNIPAAm nanogels |
Photothermo-Responsive Nanogel |
5-fluorouracil |
Chemo-photothermal synergistic therapy |
In vitro L929 cell mortality |
|
GO-hybridized pNIPAM nanogels |
Photothermally Enhanced Chemotherapy Delivered by Graphene Oxide-based Multi-responsive Nanogels |
Dox |
Chemo-photothermal synergistic therapy |
In vitro cell viability of HeLa cells |
[149,150] |
Folated PVA-based nanogels |
Folated pH degradable PVA nanogels |
Docetaxel |
Chemo-immunotherapy |
In vitro cell viability of 4T1 breast cancer cells |
[151] |